weifuchun

01/01/2023 - "However, it remains unclear whether Weifuchun is effective for atrophic gastritis. "
01/01/2023 - "To determine the effectiveness and safety of Weifuchun for chronic atrophic gastritis. "
01/01/2023 - "Weifuchun, a famous Chinese patent drug, has been widely used for chronic atrophic gastritis in China. "
01/10/2024 - "Chi006Eese herbal medicine Weifuchun Tablets (WFC) approved by the State Food and Drug Administration in 1982 has been widely used in treating a variety of chronic stomach disorders including Chronic atrophic gastritis (CAG) and Gastric precancerous lesions in China clinically. "
01/01/2023 - "Efficacy and safety of Weifuchun tablet for chronic atrophic gastritis: A systematic review and meta-analysis."

06/01/2012 - "Relative to treatment with Weifuchun tablets treatment with Weining granules resulted in a significant improvement (P < 0.05) in the scores for gastric pain, distension and stuffiness in the hypochondrium, and anorexia. "

06/01/2012 - "Relative to treatment with Weifuchun tablets treatment with Weining granules resulted in a significant improvement (P < 0.05) in the scores for gastric pain, distension and stuffiness in the hypochondrium, and anorexia. "

11/20/2021 - "A correlational study of Weifuchun and its clinical effect on intestinal flora in precancerous lesions of gastric cancer."
11/20/2021 - "Name of registry: Randomized Clinical Trial: Weifuchun Treatment on Precancerous Lesions of Gastric Cancer. "
01/01/2020 - "The Chinese medicine Weifuchun (WFC) is used in treating chronic superficial gastritis and in postoperative adjuvant treatment of gastric cancer. "

04/01/2014 - "To study the effect of Weifuchun on inflammation of Helicobacter pylori (Hp)-infected gastric epithelial cells (GES-1) and its correlation with NF-kappaB signaling pathway. "
04/01/2014 - "[Effect of Weifuchun on inhibiting inflammation of Helicobacter pylori-infected GES-1 cells and NF-kappaB signaling pathway]."